| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |